Clinical Trials
5 trialsNCT03653546 2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3 Completed
NCT01039948 2015-04-08
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
AVEO Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT00034879 2013-01-04
Iressa Expanded Access Program (EAP)
AstraZeneca
Phase 3 Completed
NCT00127829 2009-04-23
AGUS
AstraZeneca
Phase 1 Completed
NCT00635973 2009-04-22
Open-Label Extension of Other SZ1839 (Iressa) Trials
AstraZeneca
Phase 3 Completed